Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Karlijn F, Van Halewijn"'
Autor:
Patrick J E Bindels, Arthur M Bohnen, Gijs Elshout, Suzanne G M A Pasmans, Karlijn F van Halewijn
Publikováno v:
BMJ Open, Vol 14, Iss 5 (2024)
Background The Rotterdam Eczema Study was an observational cohort study with an embedded pragmatic randomised controlled open-label trial. It was conducted in children with atopic dermatitis (AD) in the Dutch primary care system. The objective of the
Externí odkaz:
https://doaj.org/article/a7ac9867132c4024bfe7ebf0a9dc6d1a
Autor:
Aviël Ragamin, Karlijn F. van Halewijn, Marie L.A. Schuttelaar, Marjolein Lugtenberg, Suzanne G.M.A. Pasmans, Gijs Elshout, Renske Schappin
Publikováno v:
European Journal of General Practice, Vol 29, Iss 1 (2023)
AbstractBackground General practitioners (GPs) have an important role in managing patients with atopic dermatitis (AD). Although pivotal, adherence to dermatological guidelines in general practice has not been assessed.Objectives To assess GPs’ per
Externí odkaz:
https://doaj.org/article/2ed9f1e884c14f9a9b80fb8e6d1918ec
Autor:
Arthur M Bohnen, Gijs Elshout, Karlijn F van Halewijn, Pieter J van den Berg, Suzanne G M A Pasmans
Publikováno v:
BMJ Open, Vol 9, Iss 6 (2019)
Externí odkaz:
https://doaj.org/article/903441f89212412caeb582b3c2731ba4
Autor:
Karlijn F. van Halewijn, Floor van der Most, Arthur M. Bohnen, Suzanne G.M.A. Pasmans, Patrick J.E. Bindels, Gijs Elshout
Publikováno v:
Dermatitis. Lippincott Williams & Wilkins
Background: Real-life data on severity and treatments in children with atopic dermatitis (AD) are needed to evaluate self-management.Objectives: To determine severity and use of topical treatments in children with AD in the general population. Furthe
Autor:
Karlijn F, Van Halewijn, Thara, Lahnstein, Arthur M, Bohnen, Pieter J, Van Den Berg, Suzanne, Gma Pasmans, Patrick, Je Bindels, Gijs, Elshout
Publikováno v:
European Journal of Dermatology, 32(1), 113-123. John Libbey Eurotext
Background: Emollients and topical corticosteroids are key elements in treating atopic dermatitis. However, there is variation in treatment recommendations as stated in international and national guidelines. To optimize the treatment of atopic dermat
Autor:
Karlijn F. van Halewijn, Tessa Warendorff, Arthur M. Bohnen, Mario Veen, Suzanne G. M. A. Pasmans, Patrick J. E. Bindels, Gijs Elshout
Publikováno v:
Skin Health and Disease, 2(3):e147. Wiley Online Library
Background: Atopic dermatitis (AD) is common in children and the majority of children can be treated by the general practitioner (GP). Various factors can influence the GP's treatment strategy and may lead to less effective treatment. The objective i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::124eae6f53bec120270b3d4641e09766
https://pure.eur.nl/en/publications/edc3f30e-6f28-49c5-8ad3-e79ca6523a1b
https://pure.eur.nl/en/publications/edc3f30e-6f28-49c5-8ad3-e79ca6523a1b
Autor:
Gijs Elshout, Pieter J van den Berg, Patrick J E Bindels, Arthur M. Bohnen, Karlijn F. van Halewijn, Suzanne G.M.A. Pasmans
Publikováno v:
BMJ Open, 9(6):e027239. BMJ Publishing Group
BMJ Open, Vol 9, Iss 6 (2019)
BMJ Open
BMJ Open, Vol 9, Iss 6 (2019)
BMJ Open
IntroductionTopical corticosteroids (TCS) of different potencies are the main treatment to control atopic dermatitis (AD). The Dutch guideline on AD for general practitioners (GPs) recommends a stepwise approach in which treatment steps are tailored
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::859b195550eda0a973a0a516bf79aa5a
https://pure.eur.nl/en/publications/f3aab508-fdb2-4bd8-9e52-78ad2b436320
https://pure.eur.nl/en/publications/f3aab508-fdb2-4bd8-9e52-78ad2b436320
Publikováno v:
Archives of Physical Medicine and Rehabilitation, 97(11), 2018-2018. W.B. Saunders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a588f65ea2b7be026126d1db38d89fa1
https://pure.eur.nl/en/publications/66403130-3f83-4207-955a-79b79823e335
https://pure.eur.nl/en/publications/66403130-3f83-4207-955a-79b79823e335
Autor:
Karlijn F. van Halewijn
Publikováno v:
Huisarts en wetenschap. 61:63-63
Ouders hebben vaak angst voor de gevolgen van corticosteroidgebruik bij de behandeling van eczeem bij kinderen. Huisartsen zijn daarom vaak terughoudend met het voorschrijven van klasse 2- of 3-corticosteroiden. Ook in de literatuur en de richtlijnen